RAS and growth signalingKRAS allele-specific, pan-KRAS and pan-RAS inhibitors, KRAS degraders and RNAi, SOS1/SHP2, RAF/MEK/ERK, EGFR/HER2/NRG1, PI3K/AKT/mTOR, CDK ● ADT Pharma · ADT-1004 ● BlossomHill · BH-501284 ▲ Tezcat
● Alterome · ALTA3263 ○ Amgen · AMG 410 ○ Astellas · ASP5834 ● BBOT · BBO-10203 ● BBOT · BBO-11818 ● Incyte · INCB186748 ● Kestrel · KST-6051 ● Kura · darlifarnib ○ Leadingtac · LT-010391 ● Lilly · LY3962673 ● Lilly · LY4066434 ○ PAQ · PT0511 ○ Pfizer · PF-07934040 ● Qilu · QLC1101 ● RasCal · RSC-1255 ○ Roche · GDC-7035
● Allist · glecirasib ● Arvinas · ARV-806 ○ Auricula · WEF-001 ○ Betta · BPI-572270 ● BMS · adagrasib ● Ensem · ETX-929 ● Erasca · ERAS-0015 ○ GenFleet · GFH276 ○ Hengrui · HRS-7172 ▲ Hummingbird · HMBD-001 ○ Ionova · INV-8989 ● Jacobio · JAB-23E73 ● Jacobio · JAB-3312 ● Lilly · olomorasib ◆ MD Anderson · iExosomes ○ Ranok · RNK08954 ● RevMed · elironrasib ● Sanofi · BLU-924 ○ Tyligand · TSN1611 ● Verastem · avutometinib+defactinib
● Astellas · setidegrasib ● Chipscreen · chiauranib ● GenFleet · VS-7375 ● Hengrui · HRS-4642 ● HUTCHMED · surufatinib ● Immuneering · atebimetinib ● Incyte · INCB161734 ○ Kvvit · DN022150 ● RevMed · zoldonrasib ◆ Silexion · SIL204
▲ Partner Tx · zenocutuzumab ● RevMed · daraxonrasib
Synthetic lethality and DNA damage responsePARP, ATR, WEE1, POLQ, PRMT5/MAT2A in MTAP-deleted tumors, replication stress
● City of Hope · AOH1996 ● Duke Street Bio · DSB2455 ● Exelixis · XL309 ● Haisco · HSK41959 ● Hansoh · HS-10502 ● IDEAYA · IDE397 ● MOMA · MOMA-313 ● Senhwa · CX-5461
● Amgen · AMG 193 ● Artios · ART0380 ● AstraZeneca · AZD9574 ● AstraZeneca · saruparib ● Cardiff Oncology · onvansertib ● Lantern · LP-184 ● Onconic · nesuparib ● Servier · S095035 ● Tango · vopimetostat
● BMS · navlimetostat
Targeted payload deliveryAntibody-drug conjugates (e.g. Claudin 18.2, TROP2, mesothelin), radioconjugates, targeted nanoparticle cytotoxics ● Armida · Targefrin ▲ Duo Oncology ▲ Migra ▲ Sanguine ▲ Traverse · TB-UA-1
▲ ArriVent · MRG007 ▲ Avacta · AVA6103 ▲ Baili-Bio · BL-M05D1 ▲ LigaChem · LCB02A ▲ Lilly · LY4337713 ▲ MacroGenics · MGC026 ▲ Medicovestor · MC001 ▲ Monopar · MNPR-101 ▲ Novartis · Lu-NNS309 ▲ Oncomatryx · OMTX705 ▲ Pfizer · PF-08046050 ▲ SK Life Science · SKL35501 ▲ Sutro · STRO-004 ▲ TORL · TORL-2-307
▲ Baili-Bio · iza-bren ▲ Bicycle · nuzefatide ▲ Daiichi Sankyo · HER3-DXd ▲ Daiichi Sankyo · I-DXd ▲ EnGeneIC · EDV ▲ Evopoint · XNW27011 ▲ GSK · risvutatug ▲ Hansoh · HS-20093 ▲ Hengrui · SHR-4375 ▲ Hengrui · SHR-A1904 ▲ Hengrui · SHR-A2102 ▲ Henlius · HLX43 ▲ Keymed · AZD0901 ▲ LigaChem · LCB84 ▲ Lumara · DPI-4452 ▲ Merck & Co. · sac-TMT ▲ Merck KGaA · M9140 ● Nuvation · NUV-1511 ▲ Zhongshan Hospital · LM-302
▲ AbbVie · Temab-A ▲ Evopoint · XNW28012 ▲ Innovent · IBI343 ▲ Lepu · MRG004A ▲ MediLink · YL201
Checkpoint and T-cell activationPD-1/PD-L1, CTLA-4, LAG-3 and other checkpoints, bispecific T-cell engagers, cytokines acting on T cells ▲ OncoTab
▲ Astellas · ASP2138 ▲ Clasp · CLSP-1025 ▲ I-Mab · givastomig ▲ Janux · JANX008 ▲ Nammi · QXL138AM ▲ Philogen · L19IL2
▲ 3SBio · SSGJ-706 ▲ Agenus · AGEN2373 ▲ Agenus · botensilimab ▲ Akeso · AK130 ▲ Akeso · cadonilimab ▲ AstraZeneca · AZD5863 ▲ AstraZeneca · oleclumab ▲ BMS · pumitamig ▲ BMS · urelumab ▲ GI Innovation · GI-108 ▲ Hengrui · SHR-1701 ▲ ImmunityBio · N-803 ▲ Innovent · IBI363 ▲ Sino Biopharm · LM-108
▲ Akeso · ivonescimab ● Arcus · quemliclustat ▲ Qilu · QLS31905 ▲ Sino Biopharm · TQB2868
Cell therapies and vaccinesCAR-T, TCR-T, NK cells, mRNA and peptide neoantigen vaccines, KRAS vaccines, dendritic-cell vaccines ■ Cambium ▲ Leukogene ■ MuCommune
▲ Akeso · AK154 ▲ Amphera · MesoPher ■ AstraZeneca · NT-175 ■ CAMS Cancer Hospital · CAT-101 ■ Changhai Hospital · CL-NK-001 ■ Changhai Hospital · CL-NK-003 ■ Corregene · KRAS TCR-T ■ Diakonos · DOC1021 ■ First Affiliated Hospital of Wenzhou Medical University · CBG131 ■ Fred Hutchinson Cancer Center · AFNT-111 ■ Hainan Cancer Hospital · CLDN18.2 DC + CAR-T ■ Hangzhou First People's Hospital · EX02 CAR-T ▲ Johns Hopkins · KRAS vaccine ■ Juncell · GC203 ■ Legend · LB1908 ▲ MD Anderson · NeoAg-VAX ○ Neowise · NW-301V ■ Peking University · KD-496 ■ Penn · TCR1188-ABC ▲ Ruijin Hospital · ABO2102 ■ Second Affiliated Hospital of Guangzhou Medical University · GPC3/MSLN CAR-γδT ■ Second Affiliated Hospital of Guangzhou Medical University · MSLN/GPC3/GUCY2C CAR-T ■ SUGH · CLDN18.2 CAR-T ■ SYSU · IX001 ■ Tianjin Cancer Hospital · CHT102 ■ UNC Lineberger · B7-H3 CAR-T ▲ WashU Medicine · neoantigen SLP ▲ Xinhe · XH001
■ A2 Bio · A2B530 ■ Affini-T · AFNT-211 ■ Anocca · ANOC TCR-T ■ Beijing Biotech · EB-DNK ■ CARsgen · satri-cel ■ Changhai Hospital · KRAS G12V TCR-T ▲ Circio · TG01 ▲ Elicio · ELI-002 ■ Essen Biotech · MSLN/CLDN18.2 CAR-T ▲ Johns Hopkins · GVAX ■ Marker · MT-601 ■ MD Anderson · TROP2 CAR-NK ■ Medigen · Magicell-NK ▲ Nanjing Drum Tower Hospital · KRAS nanovaccine ■ NCI · KRAS G12V mTCR ▲ OSE · OSE2101 ▲ Roche · autogene cevumeran ▲ Ruijin Hospital · KRAS G12V mRNA vaccine ■ University Hospital Tuebingen · CD318 CAR-T
■ GC Cell · Immuncell-LC
Innate immunity, myeloid cells and stromaCD40, CSF1R, CXCR2/CCR2, CD47, STING/TLR, oncolytic viruses, cancer-associated fibroblasts, hyaluronan, FAK, TGF-beta, CTGF ● Thetis ■ Uinta
▲ Cantargia · nadunolimab ▲ ImmuneOncia · IMC-002 ▲ Loki · Lm-LLO-TT ▲ ProDa · ProAgio ◆ TriSalus · SD-101
● Abbisko · pimicotinib ▲ Agenus · AGEN1423 ◆ AIM ImmunoTech · rintatolimod ● Amplia · narmafotinib ▲ Astellas · zolbetuximab ▲ AstraZeneca · AZD0171 ▲ Biossil · mitazalimab ▲ BMS · BMS-986253 ● Can-Fite · namodenoson ▲ CanBas · CBP501 ■ Converd · hV01 ▲ GenFleet · GFS202A ● InxMed · IN10018 ▲ Lisata · certepetide ● Nelum · NLM-001 ▲ Oncolytics · pelareorep ▲ Penn · odetiglucan ▲ Phanes · spevatamig ▲ Prestige · PBP1510 ▲ Salspera · Saltikva ● Syntrix · SX-682 ■ Theriva · VCN-01 ◆ TME Pharma · NOX-A12
▲ Akeso · ligufalimab ▲ FutureGen · FG-M108 ◆ Oncotelic · OT-101
Metabolism, epigenetics and cell deathMitochondrial and glutamine metabolism, autophagy, iron and ferroptosis, epigenetic regulators (DNMT, HDAC, BET), apoptosis ● XtremisBio · XP-524
▲ Netris · NP137 ▲ Peptomyc · OMO-103
● AbilityPharma · ibrilatazar ● Actuate · elraglusib ● Ascentawits · AST-001 ● Bold · BOLD-100 ● CG Pharma · ivaltinostat ● Corcept · relacorilant ● ImmunoGenesis · evofosfamide ● Northwestern · devimistat
● Eleison · glufosfamide ● Panbela · ivospemin
UndisclosedMechanism not public
○ Dong-A ST · DA-3501 ○ ParVation · SNV1521 ○ Pfizer · PF-08046876
○ Astellas · ASP546C ● BeyondBio · BEY1107 ▲ BioNTech · BNT329 ○ Hengrui · HRS-7058 ○ Kelun-Biotech · SKB571 ○ Majory · MR001 ○ New Cancer Cure-Bio · KN510713 ○ Rgene · BLEX 404 ○ YingLi · YL-13027
RepurposingAcademic trials of approved drugs, supplements, vitamins or herbal products
✚ arsenic trioxide ✚ belinostat ✚ calaspargase pegol ✚ canakinumab ✚ chlorphenesin ✚ dasatinib ✚ evolocumab ✚ ezetimibe ✚ fostamatinib ✚ ivosidenib ✚ leflunomide ✚ lidocaine ✚ mefloquine ✚ pentamidine ✚ pitavastatin ✚ pyrvinium ✚ ruxolitinib ✚ sotorasib ✚ talazoparib ✚ trametinib ✚ vismodegib ✚ vitamin C
✚ abemaciclib ✚ adebrelimab ✚ anakinra ✚ anlotinib ✚ apatinib ✚ aspirin ✚ Astragalus ✚ atorvastatin ✚ ATRA ✚ azacitidine ✚ benmelstobart ✚ bethanechol ✚ binimetinib ✚ bortezomib ✚ brigatinib ✚ cabozantinib ✚ camrelizumab ✚ canagliflozin ✚ celecoxib ✚ cemiplimab ✚ ceritinib ✚ chidamide ✚ ciprofloxacin ✚ cobimetinib ✚ colchicine ✚ daratumumab ✚ Dato-DXd ✚ decitabine ✚ digoxin ✚ dostarlimab ✚ durvalumab ✚ enfortumab vedotin ✚ GM-CSF ✚ H101 ✚ HDC ✚ hydroxychloroquine ✚ icaritin ✚ IL-2 ✚ inavolisib ✚ ipilimumab ✚ L-glutamine ✚ lenvatinib ✚ losartan ✚ metformin ✚ metronidazole ✚ motixafortide ✚ neratinib ✚ niraparib ✚ nivolumab ✚ olaparib ✚ palbociclib ✚ paricalcitol ✚ pegcetacoplan ✚ pembrolizumab ✚ pemigatinib ✚ ponatinib ✚ proglumide ✚ propranolol ✚ pucotenlimab ✚ QL1706 ✚ regorafenib ✚ retifanlimab ✚ rimegepant ✚ sacituzumab govitecan ✚ selinexor ✚ selumetinib ✚ simvastatin ✚ sintilimab ✚ sitagliptin ✚ sorafenib ✚ T-DM1 ✚ T-DXd ✚ tazemetostat ✚ thymalfasin ✚ tislelizumab ✚ tivozanib ✚ toripalimab ✚ tremelimumab ✚ valproic acid ✚ vemurafenib ✚ verteporfin ✚ vitamin D3 ✚ zimberelimab ✚ zoledronic acid
✚ atezolizumab ✚ bevacizumab ✚ Huaier ✚ nimotuzumab ✚ panitumumab ✚ QYHJ ✚ serplulimab ✚ tunlametinib